SCHEMBL21880888

SCHEMBL21880888

Cc1cccc(C2=NCCO2)c1N

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.40
TAAR1 Q96RJ0 1/20 0.38
CD44 P16070 1/20 0.38
HDAC8 Q9BY41 3/20 0.35
ACHE P22303 2/20 0.35
HDAC5 Q9UQL6 2/20 0.33
NISCH Q9Y2I1 1/20 0.33
CFB P00751 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
LMNA P02545 1/20 0.32
HTR5A P47898 1/20 0.32
NUDT1 P36639 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6515577 0.83 SMN1; SMN2 (0.42) SMN1; SMN2TAAR1HDAC8NISCHCFB
SCHEMBL1842317 0.82 SMN1; SMN2 (0.48) SMN1; SMN2TAAR1NISCHCFBADRA2A
SCHEMBL25193298 0.80 SMN1; SMN2 (0.40) SMN1; SMN2TAAR1HDAC8NISCHCFB
Bromide SCHEMBL5635020 0.79 SMN1; SMN2 (0.46) SMN1; SMN2TAAR1NISCHCFBADRA2A
SCHEMBL5635021 0.77 SMN1; SMN2 (0.43) SMN1; SMN2TAAR1NISCHCFBADRA2A
SCHEMBL218213 0.76 SMN1; SMN2 (0.50) SMN1; SMN2ADRA2AADRA2BADRA2C
SCHEMBL29420719 0.76 SMN1; SMN2 (0.50) SMN1; SMN2ADRA2AADRA2BADRA2C
SCHEMBL7452092 0.75 ALDH1A1 (0.44) SMN1; SMN2ACHEADRA2AADRA2BADRA2C
SCHEMBL29825088 0.75 ALDH1A1 (0.44) SMN1; SMN2ACHEADRA2AADRA2BADRA2C
SCHEMBL12670552 0.74 SMN1; SMN2 (0.34) SMN1; SMN2TAAR1HDAC8HTR5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3191479-B1 \"PROCESS FOR THE PREPARATION OF MACROCYCLIC KETONE ANALOGS OF HALICHONDRIN B OR PHARMACEUTICALLY ACCEPTABLE SALTS AND INTERMEDIATES THEREOF\ CIPLA LTD (IN) 2020-04-08 EP disclosed